[Puerarin in the treatment of poisoning of acute organophosphorous compound with toxic myocarditis].
Hou
He-gong
HG
Ju-ye People's Hospital, Shandong Province
Zhao
Li-li
LL
Liu
Yu-ping
YP
D000328:Adult; D052279:Creatine Kinase, MB Form / Q000378:metabolism; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007306:Insecticides / Q000506:poisoning*; D007328:Insulin / Q000627:therapeutic use; D007529:Isoflavones / Q000627:therapeutic use*; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008297:Male; D009205:Myocarditis / Q000139:chemically induced / Q000188:drug therapy*; D009206:Myocardium / Q000201:enzymology / Q000473:pathology; D062025:Organophosphate Poisoning; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D007306:Insecticides; D007328:Insulin; D007529:Isoflavones; D014665:Vasodilator Agents; D007770:L-Lactate Dehydrogenase; D052279:Creatine Kinase, MB Form; C033607:puerarin